The Hydrus® Microstent is a minimally invasive FDA-approved implantable device for the treatment of open angle glaucoma. The Hydrus® is a Micro-Invasive Glaucoma Surgery (MIGS) approved to be done in conjunction with cataract surgery. Since it is done at the same time as cataract surgery, no additional incisions are necessary.
The surgical procedure involves placement of an 8mm nitinol (a nickel and titanium alloy) implant through the trabecular meshwork and into Schlemm’s canal to decrease intraocular pressure via 3 mechanisms: 1) bypassing the trabecular meshwork, 2) dilating Schlemm’s Canal, and 3) spanning over 3 clock-hours (more than any other implantable MIGS device). These mechanisms combine to enhance aqueous outflow from the anterior chamber and lower intraocular pressure.
Although the Hydrus® is made of nitinol (an alloy metal), patients can safely undergo an MRI scan in most circumstances; please contact our office with any questions or visit the Hydrus® Information page.
This procedure does not involve opening-up the conjunctival tissues to access Schlemm’s canal. This is a major advantage of this procedure as it makes future glaucoma surgery (if needed) a lot simpler with less risk of failure.
Who is a good candidate for the Hydrus® Microstent?
Hydrus® is indicated for the surgical treatment of mild to moderate open angle glaucoma. It is contraindicated in patients with primary or secondary angle closure glaucoma, neovascular glaucoma, traumatic glaucoma, uveitic glaucoma, or patients with anterior chamber angle anomalies.
How does the Hydrus® Microstent work?
The Hydrus® Microstent reduces IOP by combining three mechanisms:
- Increasing aqueous outflow by bypassing the trabecular meshwork allowing aqueous to go directly into Schlemm’s Canal.
- Dilating Schlemm’s Canal to enhance aqueous outflow
- Spanning 3 clock-hours of Schlemm’s Canal, thereby reliably reducing intraocular pressure.
For more details visit the Hydrus® website.
What is involved with a Hydrus® Microstent procedure?
When you and your doctor make a decision to proceed with a Hydrus® Implant you will meet with our preoperative scheduler who will give you detailed instructions on how to prepare yourself for your upcoming surgery and what is involved in getting to the operating room for the procedure. See Preoperative instructions for more information.
This is an outpatient procedure performed in an ambulatory surgery center. In most cases, the surgery takes less than 30 minutes, though you will be at the surgery center for several hours. The surgery is usually done under local anesthesia with intravenous sedation. After surgery, the eye is covered by an eye patch and protected by a plastic shield overnight. On the morning following the surgery, the patch/shield is removed, and the eye is examined by your ophthalmologist. Eye drops are then prescribed to prevent infection and reduce inflammation. For more details, click on Postoperative instructions.
For several weeks following the surgery, your ophthalmologist will observe your eye closely and examine you frequently. It will take several weeks after your surgery for the healing to be complete. During this time, it is not unusual for your intraocular pressure, as well as vision, to fluctuate. You will be ready to change your glasses prescription at around 4-6 weeks after surgery.
Please contact the Glaucoma Associates of Texas if you have questions about treatment options for your glaucoma.